{"id":2324,"date":"2018-04-25T17:46:57","date_gmt":"2018-04-25T15:46:57","guid":{"rendered":"https:\/\/www.anderapartners.com\/?p=2324"},"modified":"2020-09-28T16:09:27","modified_gmt":"2020-09-28T14:09:27","slug":"2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics","status":"publish","type":"post","link":"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/","title":{"rendered":"2nd tour de financement \u00e0 \u20ac60m pour Corvidia Therapeutics"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-2321\" src=\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/04\/Corvidia-2.jpg\" alt=\"\" width=\"974\" height=\"493\" srcset=\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/04\/Corvidia-2.jpg 974w, https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/04\/Corvidia-2-768x389.jpg 768w, https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/04\/Corvidia-2-285x144.jpg 285w, https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/04\/Corvidia-2-446x226.jpg 446w, https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/04\/Corvidia-2-385x195.jpg 385w\" sizes=\"auto, (max-width: 974px) 100vw, 974px\" \/><\/p>\n<p>&nbsp;<\/p>\n<p>BioDiscovery 5 a particip\u00e9 au second tour de financement de la soci\u00e9t\u00e9 Corvidia Therapeutics. Corvidia est une entreprise de biotech bas\u00e9e \u00e0 Boston qui d\u00e9veloppe une mol\u00e9cule pour le traitement de l\u2019inflammation chez les patients insuffisants r\u00e9naux. BioDiscovery 5 a particip\u00e9 \u00e0 ce tour de table de 60 M$ aux cot\u00e9s des nouveaux investisseurs. Pour lire le communiqu\u00e9 de presse de Corvidia Therapeutics, <a href=\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/04\/4.25.2018-Corvidia.pdf\">cliquez ici.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; BioDiscovery 5 a particip\u00e9 au second tour de financement de la soci\u00e9t\u00e9 Corvidia Therapeutics. Corvidia est une entreprise de biotech bas\u00e9e \u00e0 Boston qui d\u00e9veloppe une mol\u00e9cule pour le traitement de l\u2019inflammation chez les patients insuffisants r\u00e9naux. BioDiscovery 5 a particip\u00e9 \u00e0 ce tour de table de 60 M$ aux cot\u00e9s des nouveaux investisseurs&#8230;.<\/p>\n","protected":false},"author":2,"featured_media":2321,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[78],"class_list":["post-2324","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biodiscovery"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>2nd tour de financement \u00e0 \u20ac60m pour Corvidia Therapeutics - ANDERA PARTNERS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2nd tour de financement \u00e0 \u20ac60m pour Corvidia Therapeutics - ANDERA PARTNERS\" \/>\n<meta property=\"og:description\" content=\"&nbsp; BioDiscovery 5 a particip\u00e9 au second tour de financement de la soci\u00e9t\u00e9 Corvidia Therapeutics. Corvidia est une entreprise de biotech bas\u00e9e \u00e0 Boston qui d\u00e9veloppe une mol\u00e9cule pour le traitement de l\u2019inflammation chez les patients insuffisants r\u00e9naux. BioDiscovery 5 a particip\u00e9 \u00e0 ce tour de table de 60 M$ aux cot\u00e9s des nouveaux investisseurs....\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"ANDERA PARTNERS\" \/>\n<meta property=\"article:published_time\" content=\"2018-04-25T15:46:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-09-28T14:09:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/04\/Corvidia-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"974\" \/>\n\t<meta property=\"og:image:height\" content=\"493\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nicolas Delsert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nicolas Delsert\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/\"},\"author\":{\"name\":\"Nicolas Delsert\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c\"},\"headline\":\"2nd tour de financement \u00e0 \u20ac60m pour Corvidia Therapeutics\",\"datePublished\":\"2018-04-25T15:46:57+00:00\",\"dateModified\":\"2020-09-28T14:09:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/\"},\"wordCount\":76,\"publisher\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/04\/Corvidia-2.jpg\",\"articleSection\":[\"andera Life Sciences\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/\",\"name\":\"2nd tour de financement \u00e0 \u20ac60m pour Corvidia Therapeutics - ANDERA PARTNERS\",\"isPartOf\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/04\/Corvidia-2.jpg\",\"datePublished\":\"2018-04-25T15:46:57+00:00\",\"dateModified\":\"2020-09-28T14:09:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/#primaryimage\",\"url\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/04\/Corvidia-2.jpg\",\"contentUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/04\/Corvidia-2.jpg\",\"width\":974,\"height\":493},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.anderapartners.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"2nd tour de financement \u00e0 \u20ac60m pour Corvidia Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#website\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/\",\"name\":\"ANDERA PARTNERS\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.anderapartners.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\",\"name\":\"Andera Partners\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg\",\"contentUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg\",\"width\":107,\"height\":44,\"caption\":\"Andera Partners\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c\",\"name\":\"Nicolas Delsert\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g\",\"caption\":\"Nicolas Delsert\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"2nd tour de financement \u00e0 \u20ac60m pour Corvidia Therapeutics - ANDERA PARTNERS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/","og_locale":"fr_FR","og_type":"article","og_title":"2nd tour de financement \u00e0 \u20ac60m pour Corvidia Therapeutics - ANDERA PARTNERS","og_description":"&nbsp; BioDiscovery 5 a particip\u00e9 au second tour de financement de la soci\u00e9t\u00e9 Corvidia Therapeutics. Corvidia est une entreprise de biotech bas\u00e9e \u00e0 Boston qui d\u00e9veloppe une mol\u00e9cule pour le traitement de l\u2019inflammation chez les patients insuffisants r\u00e9naux. BioDiscovery 5 a particip\u00e9 \u00e0 ce tour de table de 60 M$ aux cot\u00e9s des nouveaux investisseurs....","og_url":"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/","og_site_name":"ANDERA PARTNERS","article_published_time":"2018-04-25T15:46:57+00:00","article_modified_time":"2020-09-28T14:09:27+00:00","og_image":[{"width":974,"height":493,"url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/04\/Corvidia-2.jpg","type":"image\/jpeg"}],"author":"Nicolas Delsert","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Nicolas Delsert"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/#article","isPartOf":{"@id":"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/"},"author":{"name":"Nicolas Delsert","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c"},"headline":"2nd tour de financement \u00e0 \u20ac60m pour Corvidia Therapeutics","datePublished":"2018-04-25T15:46:57+00:00","dateModified":"2020-09-28T14:09:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/"},"wordCount":76,"publisher":{"@id":"https:\/\/www.anderapartners.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/04\/Corvidia-2.jpg","articleSection":["andera Life Sciences"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/","url":"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/","name":"2nd tour de financement \u00e0 \u20ac60m pour Corvidia Therapeutics - ANDERA PARTNERS","isPartOf":{"@id":"https:\/\/www.anderapartners.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/04\/Corvidia-2.jpg","datePublished":"2018-04-25T15:46:57+00:00","dateModified":"2020-09-28T14:09:27+00:00","breadcrumb":{"@id":"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/#primaryimage","url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/04\/Corvidia-2.jpg","contentUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/04\/Corvidia-2.jpg","width":974,"height":493},{"@type":"BreadcrumbList","@id":"https:\/\/www.anderapartners.com\/fr\/2nd-tour-de-financement-a-e60m-pour-corvidia-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.anderapartners.com\/fr\/"},{"@type":"ListItem","position":2,"name":"2nd tour de financement \u00e0 \u20ac60m pour Corvidia Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/www.anderapartners.com\/fr\/#website","url":"https:\/\/www.anderapartners.com\/fr\/","name":"ANDERA PARTNERS","description":"","publisher":{"@id":"https:\/\/www.anderapartners.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.anderapartners.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.anderapartners.com\/fr\/#organization","name":"Andera Partners","url":"https:\/\/www.anderapartners.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg","contentUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg","width":107,"height":44,"caption":"Andera Partners"},"image":{"@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c","name":"Nicolas Delsert","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g","caption":"Nicolas Delsert"}}]}},"_links":{"self":[{"href":"https:\/\/www.anderapartners.com\/fr\/wp-json\/wp\/v2\/posts\/2324","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.anderapartners.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.anderapartners.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/fr\/wp-json\/wp\/v2\/comments?post=2324"}],"version-history":[{"count":0,"href":"https:\/\/www.anderapartners.com\/fr\/wp-json\/wp\/v2\/posts\/2324\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/fr\/wp-json\/wp\/v2\/media\/2321"}],"wp:attachment":[{"href":"https:\/\/www.anderapartners.com\/fr\/wp-json\/wp\/v2\/media?parent=2324"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.anderapartners.com\/fr\/wp-json\/wp\/v2\/categories?post=2324"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}